Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 2

2(33.3%)

Early Phase 1

1(16.7%)

6Total

N/A(3)

Phase 2(2)

Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05551715Not ApplicableCompleted

Virtual Eye Model System for Personalised Refractive Surgery Treatment

Role: lead

NCT06231784Not ApplicableCompleted

Efficacy of the AkkoLens IOL in Patients With Cataract

Role: lead

NCT05279157Phase 2Completed

Autologous Adipose-Derived Adult Stem Cell Implantation for Corneal Diseases (ADASCs-CT-CD)

Role: lead

NCT05139511Not ApplicableUnknown

Analysis of the Results of Intense Pulsed Light Treatment Previously to Laser Refractive Surgery

Role: lead

NCT03322917Phase 2Completed

Ocular Surface Syndrome Post-lasik, Outcomes of Treatment With Platelet Rich Plasma

Role: lead

NCT02932852Early Phase 1Unknown

Autologous Adipose-Derived Adult Stem Cell Transplantation for Corneal Diseases

Role: lead

All 6 trials loaded